Clinical trial
Influence of Hydroxyproline Plasma Concentration on Its Metabolism to Oxalate
NCT02038543 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Influence of Hydroxyproline Plasma Concentration on Its Metabolism to Oxalate
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- September 30, 2013
- Completion date
- January 31, 2017
- Enrollment
- 22 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.